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Introduction
Somatic gene therapy, the alteration of genetic information, has recently received much attention and promises to provide a new approach to the prevention and treatment of a number of acquired disorders, including those of the cardiovascular system. [1] [2] [3] [4] [5] [6] [7] The first trial of human gene therapy was initiated recently in patients with inherited enzyme deficiencies and malignancies. 7 Recently, several groups have demonstrated that plasmid DNA is taken up and expressed in cardiac myocytes following direct injection into the left ventricular wall with or without adenovirus vector. [3] [4] [5] [6] However, this technique still presents several problems such as low efficiency and toxicity. [1] [2] [3] [4] [5] [6] With regard to transfer of oligonucleotide (ODN), the antisense method appears to be an innovative and attractive therapeutic strategy for blocking transcription or translation of specific genes expressed in the cardiovascular system. 8, 9 However, it appears to be difficult to transfer ODN homogeneously into the whole heart. Therefore, the gene transfer method for both ODN and plasmid DNA into the myocardium was modified in an attempt to increase efficiency and decrease the toxic response of the therapeutic DNA for the treatment of cardiovascular disease.
For introducing the vectors specifically into the myocardium, coronary infusion appears to be more efficient and nontoxic than direct injection into the myocardium, provided that the vectors can cross the endothelium. Barr and his associates 6 showed that it was possible to introduce genes through coronary arteries using replicationdefective adenovirus. However, their method needs further improvement to transfect the gene homogeneously throughout the whole heart. Moreover, the use of adenovirus is still controversial because of its cytotoxicity. This calls for alternative techniques which incorporate new kinds of vectors. We have succeeded in establishing an efficient gene transfer method using liposomes in combination with a viral envelope (HVJ (hemagglutinating virus of Japan)-liposome) without cytotoxicity in vivo. [10] [11] [12] [13] [14] It was therefore felt that the HVJliposome method might also contribute to improved efficiency of gene transfer in the cardiac myocytes without inflammatory response when delivered by coronary infusion. However, its efficacy and cytotoxicity has never been evaluated.
In this study we proved the hypothesis that coronary artery infusion of HVJ-liposome can provide homogeneous and highly efficient transfer of both ODN and plasmid DNA into the myocardium of the whole heart. Fluorescein isothiocyanate (FITC)-labeled ODN and cDNA of ␤-galactosidase (␤-gal) were introduced into the myocardium by coronary infusion of HVJ-liposome during cardioplegic arrest to elucidate its efficacy and cytotoxicity.
Results

Localization and efficiency of FITC-ODN transfection
In the first experiment comparing the efficacy and localization of delivered ODN, we introduced FITC-labeled phosphorothioate ODN (16mer, Clontech, Palo Alto, CA, USA) 9 (30 ng/ml) into rat myocardium by coronary infusion with HVJ-liposome (group H) or cationic liposome (group C) and during cardioplegic arrest (group A) or while the heart was beating (group B). The rat hearts (n = 24) were divided into four groups according to the different combinations of vectors and administration methods: groups H/A, H/B, C/A and C/B (Table 1 , n = 6).
The H/A group resulted in an efficient and diffuse transfer of F-ODN into nuclei of more than 70% of the myocytes (Figure 1a The percentage of FITC staining nuclei of myocytes was 71 ± 17% in the H/A group, 8 ± 6% in the C/A group, 0% in the C/B group and 16 ± 12% in the H/B group, respectively ( Table 1) . The H/A group showed a significantly higher percentge of FITC staining nuclei of myocytes than did the other three groups.
Intensity of FITC (fluorescence intensity (FI) per gram ventricular wet weight) was 986 ± 128 FI/g in the H/A group, 132 ± 72 FI/g in the C/A group, 77 ± 96 FI/g in the C/B group and 332 ± 102 FI/g in the H/B groups, respectively ( Figure 2) . The H/A group showed significantly higher intensity of FITC than did the C/A, the C/B and the H/B groups. A comparison between the H/A and the C/A groups showed that the efficiency of HVJliposome was about 10 times higher than that of cationic liposome. A comparison between the H/A and the H/B groups showed that this method was about three times more efficient during cardioplegic arrest than when the heart was beating.
Efficiency of protein synthesis
In the second experiment, HVJ-liposome complex containing cDNA of ␤-galactosidase was applied to the heart of rats by means of the H/A, H/B, C/A and C/B methods in order to demonstrate the expression of the transferred gene (Table 1 , n = 5).
In the macroscopic findings of the expression of ␤- Figure 4 ). ␤-Gal expression was apparent by Western blotting analysis at day 3 after transfection as compared with the control heart transfected with empty liposome and expression continued until at least 14 days after transfection. However, its expression was not detected at day 28 after transfection ( Figure 5 ).
Myocardial damage
The toxicity of this method for the myocardium was histologically and biochemically analyzed by comparison of the rats transfected by the HVJ-liposome method (n = 5) with sham-operated rats (control group) without HVJliposome (n = 4).
All hearts were contracting equally vigorously before and after excision. Histologically, no animal showed any acute cellular rejection or irreversible damage in any layer of the myocardium on day 7 after transfection ( Figure 6 ).
There was no significant increase in the serum level of CPK in the rats transfected with HVJ-liposome compared with sham-operated rats without HVJ-liposome for 7 days after transfection ( Figure 7 ).
Discussion
The results of this study clearly demonstrate that the hearts were transfected with both FITC-oligonucleotide and ␤-galactosidase c-DNA by administering the HVJliposome by coronary infusion, especially during cardioplegic arrest. The DNA was transferred to cardiac myocytes both in the epicardium and endocardium of the whole heart. The results of FITC-oligonucleotide transfer demonstrate that the DNA can be transferred to the nuclei of endothelial cells and myocytes in the whole heart. A comparison between different groups transfected with HVJ-liposome (H/A group) and cationic liposome (C/A group) showed that the transfection efficiency of HVJ-liposome was about 10 times higher than that of cationic liposomes. These results demonstrate that genes can be effectively transferred to the nuclei of endothelial cells and myocytes through the coronary artery when HVJ-liposome is used as a vector. A comparison of groups transfected during cardioplegic arrest (H/A group) and while the heart was beating (H/B group) shows that this method is about three times more efficient during cardioplegic arrest than when used on the beating heart. This suggests the necessity for an incubation period to allow adhesion of HVJ to endothelial cells in order to improve the efficiency of gene transfer even with the HVJ-liposome method. Moreover, these results with FITC-oligonucleotide indicate the efficiency of this gene transfer method with HVJ-liposome into the myocardium for antisense therapy.
In the second experiment, more than 50% of myocytes showed expression of ␤-galactosidase proving gene expression following transfer of the gene into the nuclei by this method. This expression continued until at least 14 days after transfection. These findings prove our hypothesis that the whole heart can be transfected for 14 days as a result of coronary infusion of HVJ-liposome. Although more substantial technical and experimental improvements appear to be needed, the initial success with our method may eventually lead to novel approaches for gene therapy, including antisense therapy of cardiovascular disease 8, 9 during surgery. Zhu et al 15 indicated the possibility of a single intravenous injection of expression plasmid for systemic gene expression including the myocardium. However, this procedure appears to have some problems such as targeting the heart with low efficiency for myocytes. For targeting and diffuse delivery of genes into all layers of the myocardium, the selective infusion of genes through the coronary artery seems also to be superior to direct injection into the myocardium. [16] [17] [18] For coronary infusion of the vectors, either the use of a coronary catheter while the heart is beating or a surgical approach during cardioplegic arrest appears to be most suitable for clinical application. Barr and his associates 6 improved the efficiency of gene transfer into the myocardium by intracoronary gene transfection with adenovirus. However, gene expression in their experiment was observed only in approximately 32% of myocytes 6 suggesting a limited transfected area of the myocardium when the whole heart needs to be transfected. In contrast, we have improved the result of intracoronary gene transfection and approximately more than 50-70% of myocytes in the whole heart were transfected with the introduced gene. The differences between Barr's and our techniques are mainly the incubation period for the beating heart or the cardioplegic arrested heart, and the viral vectors with adenovirus or HVJ. The combination of cardioplegic arrest and excision of the heart for in vivo gene transfer provides the same situation as the in vitro experiment, because of the specific binding period during an adequate incubation time. In the in vitro experiment, it is important that the incubation time is sufficient to allow transfection of the gene to the cells. In contrast, the beating heart cannot provide enough contact time between the cells and genes because the dynamic coronary circulation washes out these genes rapidly, and a more specific mechanism for cell-gene contact such as antigenantibody adhesion may be needed to improve transfection efficacy in the beating heart. Therefore, the combination of HVJ-liposome and an adhesion period for endothelial cells and viral vectors might be important for gene transfection into the whole heart.
Animal models using surgical procedures may offer a unique model to the investigator for the study of gene therapy. 19 In this study a transplantation model was used because of technical considerations such as the maintenance of enough incubation time for HVJ-liposome and endothelial cells, and the maintenance of the transfected rat heart long enough to allow for protein synthesis. However, cardiopulmonary bypass and/or left ventricular assist system (LVAS) appear to be alternatives when applied in a clinical situation or in experiments with larger animals. Under experimental conditions our HVJliposome method by coronary infusion during cardioplegic arrest appears to be more invasive than cathetermediated coronary infusion where the efficiencies are comparable. With respect to a gene therapy application in a clinical situation, however, this method seems to be feasible for the cardioplegically arrested heart during open heart surgery or for the harvesting of donor hearts. Thus, our results suggest that surgery may offer opportunities to perform in vivo gene delivery.
One of the inevitable problems with existing methods for gene transfer is the significant myocardial damage. For instance, direct injection of plasmid DNA still has the potential to elicit inflammatory responses resulting in a deleterious effect on myocardial function and restriction of the transfected area in the myocardium, thus preventing alteration of the genetic information of the whole heart. 1, 2, 6 Regarding the promising viral vectors, adenovirus is still controversial both because of its antigenicity and cell toxicity. developed T cell lymphoma as a result of contamination with a wild-type retrovirus. 21 In our study, no animal showed any irreversible damage or morphological alterations such as contraction band necrosis in any of the layers of the myocardium. Inactivation of HVJ with UV irradiation may be one way to prevent the significant inflammatory response because only its surface protein F and HN on the viral envelope are needed when used for gene transfection. HVJ-liposome demonstrated low titers of antibody and did not generate CTL activity to hepato-
Figure 5 Western blotting analysis showed apparent expression of ␤-gal at day 3 after transfection and its expression continued until 14 days after transfection. G, samples from ␤-gal transfected hearts with HVJ-liposome. G1, G2 (at day 3), G3 (at day 14) and G4 (at day 28) after transfection. C, samples from control heart transfected with empty vectors.
Figure 6 Neither HVJ group (a) nor control group (b) showed any acute cellular rejection or irreversible damage in any layer of the myocardium on day 7 after transfection.
cytes. 22 Thus, HVJ-liposome appears to be safe for myocytes, holding promise for the clinical application of this method.
The mechanism by which HVJ-liposome acts as a vector for the myocardium remains unknown. Regarding HVJ-liposome for in vivo gene transfer into the arterial wall, Yonemitsu et al 23 reported that the reporter gene can be transferred without any severe endothelial denudation. They speculated that the structural characteristics of HVJ-liposomes, such as being soft and flexible, caused the increase in permeability through the intracellular junctions among the endothelial cells. 22 Thus, it is apparent that HVJ-liposome can migrate through the vessel walls and reach the nuclei of myocytes. No other vectors have been reported to be useful for transmigration of genes without significant damage when administered through coronary arteries. In contrast, fusion of HVJ and plasma membranes occurs quickly, within 1-2 min after binding. 24 Liposomes composed of anionic lipid are able to hold 500-1000 molecules of plasmid DNA per liposome. 25 Macromolecules encapsulated in HVJ-liposome appear to be introduced directly into cytoplasm by the fusion of the viral protein with the cell membrane, thus bypassing the lysosomal pathway. 22 The introduced DNA is efficiently translocated into the nucleus with the help of HMG-1 nuclear protein. 10 Therefore, it is speculated that the combination of HVJ-mediated membrane fusion and the hydrophobic nature of liposome with negative charge may contribute to the high efficiency of gene transfer into the myocardium as compared with other methods.
The limit of gene transfection with HVJ-liposome may be as much as 14 days in view of our results from the Western blotting analysis. This agrees with the result obtained by Yonemitsu et al 23 who reported that exogenous gene transfected into arterial wall with HVJ-liposome is expressed for at least 14 days. We would expect more long-term expression of the transfected gene when using a more suitable gene promoter. This seems relatively short compared with transfection with other vectors. 6 However, repetitive administrations of HVJ-liposome 11 enable persistent gene expression in the liver, 22 and may promise clinical application as compared with other vectors. To improve this method especially for clinical applications, further investigation is needed including the basis mechanism by which HVJ functions as a viral vector and a housekeeping gene promoter for the myocytes.
In summary, the results of this study proved our hypothesis that a gene can be transfected into the whole heart for 14 days by coronary infusion of HVJ-liposome during cardioplegic arrest. To our best knowledge, this is the first report of an efficient technique for gene tranfer into cardiac myocytes for the whole heart without significant damage. Ours appears to be an efficient method for gene transfer into the myocardium providing a new tool for research and therapy for heart diseases during surgery.
Materials and methods
Animals
Adult Sprague-Dawley rats weighing 250 to 300 g were used for this experiment. All rats were anesthetized by intraperitoneal injection of sodium pentobarbital (5 mg/100 g body weight).
Animal care
This study was carried out under the supervision of the Animal Research Committee in accordance with the Guideline on Animal Experiments of Osaka University Medical School and the Japanese Government Animal Protection and Management Law (No. 105).
FITC-oligonucleotide
In the first experiment, we introduced FITC-labeled phosphorothioate oligonucleotide (F-ODN; 5Ј-CTT-CGT-CGG-TAC-CGT-C-3Ј) into the myocardium by the HVJliposome method to evaluate the localization of the transferred DNA. F-ODN was kindly provided by Clontech. 12, 13 ODN was labeled with FITC on the 3Ј and 5Ј ends of the ODN using fluorescein-ON phosphoramidite.
Construction of plasmid
In the second experiment, we introduced the cDNA plasmid of ␤-galactosidase (␤-gal) to evaluate the possibility of protein synthesis induced by the transferred genes. ␤-Gal was prepared as described previously. 9 Briefly, pActc-myb (a gift from Dr Ishii, Institute of Physical and Chemical Research, Tokyo, Japan) containing the 5Ј-promoter region (370 base pairs) and the first intron (900 base pairs) of the chicken ␤-actin gene was restricted with XhoI-BamHI and cloned into the SalI-BamHI site of pUC19. This plasmid (pUC-Act-c-myb) was restricted with NcoI-XbaI to remove c-myb and then ligated with SalI linker (8mer, Takara Syuzo). The Escherichia coli ␤-galactosidase (␤-gal) gene (3.1 kb), isolated from pMC1871 by restriction with SalI, was cloned into this site.
Preparation of HVJ-liposome
Liposomes containing plasmid DNA and high mobility group 1 (HMG-1) nuclear protein, which contributes to the enhancement of gene mobility in the cytoplasm to the nuclei, were constituted as previously reported. [8] [9] [10] [11] 15 Briefly, dried lipid (phosphatidylserine, phosphatidylcholine and cholesterol combined at a weight ratio of 1:4.8:2) was mixed with plasmid DNA (200 g) (previously incubated at 20°C for 1 h with HMG-1), shaken vigorously, and sonicated to form the liposome. Purified HVJ (Z strain) was inactivated by UV irradiation (110 erg/mm 2 /s) for 3 min just before use. The liposome suspension mixed with HVJ was incubated at 4°C for 10 min and at 37°C for 30 min. The HVJ-liposome complex was collected for use, after the removal of free HVJ. This preparation method has been optimized to achieve maximal transfection efficiency as reported previously.
Preparation of cationic liposome
For the group using cationic liposome (group C) in the first experiment, F-ODN (30 ng) was gently mixed with 250 g of the cationic lipid (Lipofectamine (2,3- 
, BRL Life Technologies, Gaithersburg, MD, USA) in 500 l of sterile saline (0.127 m NaCl) and allowed to form a DNA-cationic lipid complex. 26 Experimental protocol of gene transfection The hearts of rats in group A were arrested with cold crystalloid cardioplegic solution (4°C) and isolated. A coronary catheter (24 gauge) was then inserted and 500 l of HVJ-liposome complex or cationic liposome complex were delivered into the coronary arteries through the aortic cannula during cardioplegic arrest (less than 15°C). In the hearts of rats in group B, the coronary catheter (24 gauge) was inserted through the right common carotid artery and the same volume as for group A of HVJ-liposome complex or cationic liposome complex was delivered into the coronary arteries while the hearts were beating. Then, the hearts treated with either method were heterotopically transplanted into the abdomens of recipient rats of the same strain according to the method of Ono and Lindsey. 27 Briefly, the abdomen of the recipient rat was opened and its lower abdominal aorta and inferior vena cava were both exposed and clamped. The ascending aorta of the transfected donor heart was anastomosed to the recipient lower abdominal aorta with continuous over and over suture using 8-0 nylon. Then, the trunk of the donor pulmonary artery was anastomosed in the same manner. All hearts showed good contraction after release of the clamps. Mean time of cold ischemia (less than 15°C) was 25 ± 12 min. All animals were killed on day 3 after transfection.
Evaluation of FITC-oligonucleotide
In the histological examination, the hearts were isolated, fixed with 3% paraformaldehyde, frozen at −80°C, cut into thin sections, and examined under fluorescence microscopy and micrographs taken. Then the same section was stained with hematoxylin and eosin and photographed under light microscopy. The percentage of FITC staining nuclei of myocytes was semiquantitatively evaluated by means of the comparison between the fluorescence micrograph and normal light micrograph both derived from the same area on the same section. To quantify the level of the FITC-ODN transferred into the nuclei of myocytes, the hearts were homogenized by digital homogenizer (Iuchi, Tokyo, Japan) for 3 min to break the sarcolemma and the nuclear envelope of the myocytes, centrifuged (1500 g) for 10 min and the level of FITC in the supernatant was measured at 520 nm by fluorescence and spectrophotometry (RF-1500, Shimadzu, Kyoto, Japan) and its intensity was described as fluorescence intensity per gram wet weight of rat ventricle. 28 Analysis of ␤-galactosidase The hearts were fixed with 2.5% glutaraldehyde, frozen at −80°C and cut into thin sections stained with 5-bromo-4-chloro-3-indolyl ␤-d-galactosidase (X-gal) for identification of the expression of ␤-galactosidase in the myocardium. 9 Then, these sections were counterstained by hematoxylin and eosin staining. To semiquantify the efficacy of protein synthesis caused by the transferred genes, more than 200 myocytes were evaluated at the randomized areas (magnification ×100) and the percentage of the ␤-gal expressing myocytes was calculated.
For macroscopic findings of the expression of ␤-gal, the hearts were cut into thick sections, fixed with 2.5% glutaraldehyde and directly stained with X-gal.
Western blotting analysis for ␤-galactosidase Of the frozen tissue 0.5 was homogenized and extracted with RIPA (PBS, 1% NP 40, 0.5% sodium deoxycholate, 0.1% SDS) buffer (with freshly added inhibitors: 10 l/ml PMSF in isopropanol, 30 l/ml aprotinin (Aprotinin; Sigma, St Louis, MO, USA), 10 l/ml sodium orthovanadate in frozen aliquots). They were microfuged at 15 000 g for 20 min at 4°C, the supernatant was removed and microfuged again. The supernatant was corrected and the protein assay was performed with a Bio-Rad Protein assay kit (Bio-Rad Laboratories, Richmond, CA, USA). Western blot analysis was performed on slab gels following Laemmli at an acrylamide concentration of 6%. Each sample loaded in this study contained 50 g of total protein. Primary antibody for ␤-galactosidase (␤-galactosidase (Ab-1); Oncogene Science, Manhasset, NY, USA) was diluted with 1% gelatin/casein in phosphate-buffered saline, preincubated at room temperature for 1 h, then incubated with the protein transferred polyvinylidene difluoride (PVDF-plus, Micron Separations) sheets at room temperature for 1 h. The sheets were then treated with peroxidase-conjugated antimouse IgG and immunoreactive proteins were visualized with Amersham ECL reagents (Amersham International, Bucks, UK).
Damage to myocardium
To investigate the damage to the myocardium, histological and biochemical analyses were performed. For histological analysis, light microscopy was used. For biochemical analysis, serum level of creatine phosphokinase (CPK) was measured in the blood obtained from the tail veins.
Statistics
All values are expressed as mean ± s.e.m. Student's unpaired t test for a comparison between two groups, or analysis of variance (ANOVA) and subsequent Duncan's multiple range test for a comparison among more than three groups were used to determine significant difference. Statistical significance was set at P Ͻ 0.05.
